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Abstract
Background—Preference-based measures of health-related quality of life all use the same dead
= 0.00 to perfect health = 1.00 scale, but there are substantial differences among measures.
Objective—The objective is to examine agreement in classifying patients as better, stable, or
worse.
Design—The EQ-5D, Health Utilities Index Mark 2 and Mark 3, Quality of Well-Being – Self-
Administered, Short-Form 36 (Short-Form 6D), and disease-targeted measures were administered
prospectively in two clinical cohorts.
Setting—The study was conducted at academic medical centers: University of California, Los
Angeles; University of California, San Diego; University of Wisconsin-Madison; and University
of Southern California.
Patients—Patients undergoing cataract extraction surgery with lens replacement completed the
25-item National Eye Institute Visual Function Questionnaire (NEI-VFQ-25). Patients newly
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refereed to congestive heart failure specialty clinics completed the Minnesota Living with Heart
Failure Questionnaire (MLHF).
Measurements—In both cohorts subjects completed surveys at baseline, one and six months.
The NEI-VFQ-25 and MLHF were used as gold standards to assign patients to categories of
change. Agreement was assessed using kappa.
Results—376 cataract patients were recruited. Complete data for baseline and the one-month
follow-up were available on all measures for 210 cases. Using criteria specified by Altman,
agreement was poor for six of nine pairs of comparisons and fair for three pairs. 160 heart failure
patients were recruited. Complete data for baseline and the six-month follow-up were available for
86 cases. Agreement was negligible for five pairs and fair for one.
Limitations—The study was conducted on selected patients at a few academic medical centers.
Conclusions—The results underscore the lack of interchangeability among different preference-
based measures.
Introduction
Preference-based measures of health-related quality of life (HRQL) are needed for
monitoring population health and for program evaluation for comparative effectiveness
research. Most importantly, these measures are required for estimating quality-adjusted life
years (QALYs). A number of widely used generic preference-based measures are available
such as the EQ-5D (1), Health Utilities Index Mark 2 (HUI2) and Mark 3 (HUI3)(2), the
Quality of Well-Being - Self-Administered scale (QWB-SA) (3),and Short-Form 6D
(SF-6D) (4;5). Although these measures share a common core (6;7) and all include items on
mobility, mental health, and pain, there are also important differences with respect to which
attributes (dimensions or domains of health status) are included. HUI and the QWB-SA
include vision, hearing, speech, and dexterity; the EQ-5D and SF-6D do not. The QWB-SA
is unique in that it includes 58 symptoms or health problems, only some of which are
included in the other measures. These measures also differ in the range of function or
symptom severity covered in each attribute. The QWB-SA asks respondents if they have or
do not have a problem such as pain and stiffness; in contrast HUI and SF-6D have gradients
such as the categories mild, moderate, and severe pain.
These measures also differ with respect to the methods that were used to elicit preference
scores with which to estimate their respective multi-attribute scoring functions, the methods
for estimating those functions, and their functional forms (8). For instance, the QWB-SA
scoring function is based on valuations using the visual analog scale (VAS) and a linear
additive scoring function. SF-6D is based on the standard gamble (SG) and an ad hoc
modified linear additive functional form. EQ-5D is based on the time trade-off (TTO) and an
ad hoc modified linear additive functional form. HUI is based on transformed VAS and SG
scores and a multiplicative functional form.
It is therefore not surprising that several investigators that have used two or more measures
have concluded that the scores from these measures are not interchangeable (9–14). Further
there is evidence from prospective studies that the estimates of absolute and/or relative
change (responsiveness, including effect size (ES) and the standardized response mean
(SRM)) (15) often do not agree (12;16–19).
The objective of this paper is to examine agreement among the above measures in
classifying patients into the same categories of change: We want to know if the measures
agree on which patients get better, remain stable, or get worse. Data from two prospective
cohort studies that employed all five of the above measures as well as disease-targeted
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measures are used to assess agreement among these measures: one study of patients
undergoing cataract surgery, the other of patients referred for treatment for congestive heart
failure by a specialty clinic.
This paper builds on an earlier paper (19) based on the data from the same study. That paper
provided cohort-level estimates of responsiveness (SRM) for each of the five preference-
based measures in each of the two cohorts. Responsiveness varied among measures and
across cohorts. Results from that paper underscore the lack of interchangeability of scores
among these measures.
This paper asks an important follow-up question. Even if overall responsiveness differs
among measures, do they agree on who gets better, who gets worse, and who was stable?
Methods
Patients
Subjects for both components of the study had to be at least 35 years of age, able to give
informed consent, able to hear and understand instructions in English, and have sufficient
vision and ability in reading and writing English to complete questionnaires (19). Cataract
Surgery. Patients were undergoing cataract extraction surgery with lens replacement.
Patients were excluded if undergoing simultaneous glaucoma, corneal, or vitro-retinal
procedures, or if they were unable to read large print versions of questionnaires. Heart
Failure. Patients were newly referred to congestive heart failure clinics. Inclusion criteria
included evidence of the presence of heart failure for at least three months defined as a left
ventricular ejection fraction less than 40%. Patients classified as Class IV in the New York
Heart Association system, those with a recent (≤ six months) myocardial infraction, unstable
angina, recent (≤ three months) coronary artery bypass graft surgery, those on the heart
transplant list, or those with recent (≤ three months) ventricular tachycardia were excluded.
Participants were recruited from four academic medical centers: The University of
California, Los Angeles (UCLA), the University of California, San Diego (UCSD), the
University of Wisconsin, and the University of Southern California (cataract patients). The
study was approved by the Institutional Review Boards at each of these institutions (UCLA
IRB #G05-06-096-11; UCSD Project #070435; Wisconsin M-2005-1171; USC
#HS-06-00493).
Procedures
At enrollment patients were given a packet of self-administered questionnaires to complete
and mail back to the UCSD Health Services Research Center (HSRC) within seven days.
The HSCR mailed out the same packet for the one- and six-month follow up surveys.
Measures
The study included five of the most commonly used preference-based measures (8). There is
substantial evidence on the reliability, cross-sectional construct validity, and responsiveness
(longitudinal construct validity) of each of these measures in a wide variety of applications.
The study also used a widely used disease-targeted measure for vision (25-Item National
Eye Institute Visual Function Questionnaire) (NEI-VFQ-25)(20–22) and a prominent
disease-targeted measure for heart failure (Minnesota Living with Heart Failure
Questionnaire) (MLHF) (23–26).
EQ-5D-3L (hereafter: EQ-5D)—The health-status classification system of EQ-5D
includes five attributes (mobility, self-care, usual activity, pain/discomfort, and anxiety/
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depression) with three levels (no problem, some problem, extreme problem) per attribute
(1). The EQ-5D also includes a visual analog scale (VAS) on which respondents provide a
rating of their current overall health; the analyses reported here do not include the VAS
scores. Health status at a point in time for a subject is described as a five-element vector, one
level for each attribute. Preference-based scores for EQ-5D health states were derived using
a scoring function based on TTO preferences elicited from a random sample of community
dwelling residents of the United State and estimated with an ad hoc modified linear additive
utility function (27). Scores are defined on the conventional scale in which dead = 0.00 and
perfect health = 1.00; EQ-5D scores range from −0.11 (states worse than dead) to 1.00.
Health Utilities Index Mark 2 (HUI2) and Mark 3 (HUI3) (28;29)—HUI2 includes
seven attributes: sensation [vision, hearing, speech], mobility, emotion, cognition, self-care,
pain, and fertility. (The item on fertility was not administered in this study; fertility was
assumed to be normal, level 1.) There are four or five levels per attribute in HUI2. The
multiplicative HUI2 scoring function is based on preference elicitation using the VAS and
SG from a random sample of community-dwelling subjects in Canada (28). Single-attribute
utility scores are on a scale in which 0.00 is the score of the most disabled level in that
attribute and 1.00 is the score for level 1, no problem or disability in that attribute. Overall
HUI2 scores vary from −0.03 to 1.00. In addition to the overall HUI2 score, the single-
attribute HUI2 sensation score was included in the analyses of data from the cataract cohort
because of its relevance as a specific measure of visual function.
HUI3—HUI3 includes eight attributes (vision, hearing, speech, ambulation, dexterity,
emotion, cognition, and pain and discomfort) with five or six levels per attribute. The
multiplicative HUI3 scoring function is based on preference elicitation using the VAS and
SG from a random sample of community dwelling subjects in Canada (29). Overall HUI3
scores vary from −0.36 to 1.00. In addition the overall HUI3 score, the single-attribute HUI3
vision score was included in the analyses of data from the cataract cohort because of its
relevance.
Self-Administered Quality of Well-being Scale (QWB-SA)—The QWB-SA assesses
self-reported functioning using a series of questions designed to record limitations in the
previous three days, within three separate domains (mobility, physical activity, and social
activity). In addition, QWB-SA includes a series of questions that ask about the presence or
absence of different symptom/problem complexes. The four domain scores are combined
into a total score that provides a numerical point-in-time expression of well-being that
ranges from zero (0.00) for dead to one (1.00) for asymptomatic optimum functioning. The
original QWB obtained preference ratings of 856 people from the general population (30).
The QWB-SA used convenience samples to model preference for case descriptions and the
models were shown to be highly correlated with the population ratings in the original QWB
general population preferences elicitation survey. Scores range from 0.00 to 1.00; 0.09 is the
minimum for a living health state. The self-administered QWB-SA has been shown to be
highly correlated with the interviewer-administered QWB and to retain the psychometric
properties. Extensive evaluation of reliability and validity have been published (3;3;30–32).
Self-Rated Health (SRH)—The self-rated health item (33), “In general, would you say
that your health is excellent, very good, good, fair, or poor,” is a widely used measure of
overall health and was therefore included in the analyses.
Short-Form 6D (SF-6D)—SF-6D is a preference-based measure based on a subset of
items from the SF-36 (or SF-12)(4;5;34). SF-6D includes six attributes (physical
functioning, role limitations, social functioning, pain, mental health, and vitality) with four
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to six levels per attribute. The scoring function is based on SG preferences elicited from a
random sample of community-dwelling subjects in the United Kingdom and estimated using
an ad hoc linear additive functional form (4).
25-Item National Eye Institute Visual Function Questionnaire (NEI-VFQ-25)—
The NEI-VFQ-25 was designed to capture the influence of vision on a number of
dimensions of HRQL including emotional well-being and social functioning (20–22). The
NEI-VFQ-25 includes 25 items covering general health, general vision, near vision, distance
vision, driving, peripheral vision, color vision, ocular pain, role limitations, dependency,
social function, mental health, and expectations. The total score ranges from 0 to 100 with
higher scores signifying better (less impaired) vision.
Visual Function Questionnaire - Utility (VFQ-UI)—Recently a preference-based
index scoring system has been developed for the NEI-VFQ-25 (35) (Kowalski et al.
submitted; Rentz et al. submitted), the VFQ-UI. The VFQ-UI includes a single item
representing each of six domains of the NEI-VFQ: near vision (see well up close), distance
vision (going out for films, sports events), role function (limited work time due to vision),
mental health (worry about doing things that may embarrass because of vision), vision
dependency (stay at home because of vision) and social function (see people’s reaction to
things I say). The items were selected to cover a range of vision-related functioning using
Rasch analyses on samples of patients with central vision loss or peripheral vision loss. The
VFQ-UI defines eight vision-related health states ranging from no difficulty to stopped
doing work scored on a 0.00 (dead) to 1.00 perfect health range using time-tradeoff derived
preference scores.
Minnesota Living with Heart Failure Questionnaire (MLHF)—The MLHF includes
21 items covering symptoms, mental health, social life, fatigue, appetite, mobility, sleep,
sexual activity, work and recreational activities, and side-effects of treatment (23–26).
Overall scores range from 0 to 105 with higher scores signifying greater impairment (lower
HRQL).
Criteria for clinically important change
It is important to assess a measured change with respect both to its statistical significance
and its clinical importance or magnitude. Guyatt et al. (p 377) (36) provide a definition of a
clinically important difference: “The MID [minimum important difference] is the smallest
difference in score in the domain of interest that patients perceive as important, either
beneficial or harmful, and which would lead the clinician to consider a change in the
patient’s management.” There are two major methods for determining the clinical
importance of a given magnitude of change: anchor-based and distribution-based approaches
(36–43). In the anchor-based approach, the change in HRQL score is related to a known
anchor. The anchor itself must be an independent measure and be readily interpretable such
as the categories of the New York Heart Association functional classification system or
ability to climb a flight of stairs. Further, there must be an appreciable association between
the anchor and the target measure (36). In the distribution-based approach the magnitude of
change is compared to some measure of the variability of scores. Cohen’s guidance on
classifying effect sizes is an example: 0.20 small; 0.50 medium; 0.80 large (44). The anchor-
based approach provides an estimate of clinically important change while the distribution-
based approach provides a basis for translating raw score change into standardized units that
can be used for comparisons with estimates from prior studies or existing rules of
thumb(40).
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For this study, a change of 0.03 or more in the overall preference score for each of the
preference-based measures is interpreted as a clinically important change (2;8;11;37;45–56).
Empirical estimates of clinically important change (differences) for the five preference-
based measures vary from 0.01 to 0.08 with 0.03 being well represented in estimates for
each of these measures.
For the single-attribute utility scores for HUI2 sensation (which includes vision) and HUI3
vision the guideline for a clinically important difference is 0.05(2). For the NEI-VFQ-25, a
change of 5.0 or more in the composite score on a 0 to 100 scale is regarded as clinically
important (57). For the MLHF instrument, a change of 5.0 or more in the total score (0 to
105) is regarded as clinically important (23–25). For self-rated health (SRH: excellent, very
good, good, fair, poor), a movement of one or more categories is considered clinically
important.
Statistical Analyses
Previous work (19) indicated that patients undergoing cataract surgery changed substantially
between baseline and the one-month follow-up survey (after surgery) and were typically
then stable in the period between the one- and six-month follow-ups. Analyses for the
cataract cohort therefore focus on change between the baseline to one-month follow-up.
Improvement was more gradual in the heart failure cohort (19). Analyses focus on the
change between baseline and the six-month follow-up.
Measures of Agreement
Relative agreement in direction and size among change scores for the 10 measures used in
the cataract cohort and seven measures used in the heart failure cohort was assessed using an
intra-class correlation coefficient (ICC) based on a two-way mixed analysis of variance
model (measures fixed, patients as random). Agreement between the disease-targeted
measure (NEI-VFQ-25 for cataracts, MLHF for congestive heart failure) and each of the
five (EQ-5D, HUI2, HUI3, QWB-SA, and SF-6D) preference-based measures and SRH as
to whether patients had improved, were stable, or got worse was assessed using a number of
measures including the per cent agreement, kappa (unweighted and weighted), and the Delta
statistic, a measure of agreement that is less sensitive than kappa to the marginal
distributions (58). The degree of agreement (kappa) were interpreted according to the
criteria suggested by Altman (59): <0.20 poor; 0.21 – 0.40 fair; 0.41 – 0.60 moderate; 0.61 –
0.80 good; 0.81 – 1.00 very good. In addition, regarding the two disease-specific measures
as gold standards, the sensitivity of each of the six generic measures to change on the
disease-targeted instruments was estimated using receiver operating characteristic curves
(ROC) analyses. The ROC analyses determine if the results are sensitive to the choice of the
threshold for clinically important change (0.03) on the preference-based measures.
Primary analyses were conducted on a sub-set of subjects for whom there is complete data at
baseline and the one month follow-up (cataract cohort) and baseline and the six-month
follow-up (heart failure cohort) for all of the measured included in the analyses. Thus, any
differences in agreement across measures will not be the result of differences in the subjects
excluded due to missing data. Secondary data analyses were conducted for the larger sample
size for which data at baseline and the designated follow-up (all available pairs with
complete data) and the sample size vary by pair of measures.
Results
A total of 376 cataract patients and 160 heart failure patients were recruited to the study. The
majority of patients were white, cataract patients tended to be female, heart failure patients
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tended to be male, most cataract patients were 65+, and the heart failure patients tended to
be younger with the majority in the 45–64 age group (Table 1).
For the cataract cohort data for baseline and one-month follow up assessments were
available for 315 of the 376 cases. Complete data for all pairs for all measures were
available for 210 cases. The distribution of demographic variables for those with and
without complete data was similar and there were no statistically significant differences
between the two groups.
For the heart failure cohort data for baseline and the six-month follow-up assessments were
available for 110 of the 160 cases. Complete data for all pairs for all measures were
available for 86 cases. Those with missing data were older than those without missing data
and the difference between the two groups was statistically significant.
The overwhelming majority of respondents, 93%, reported that no one helped them to
complete the questionnaires; 7% reported receiving help. Among those who received any
help, 90% reported that someone read the questions to them; 55% reported that someone
wrote the answers on the questionnaire for them; 6% reported that someone answered the
questions for them; 4% reported that someone translated the questions into their language
for them; and 9% reported some other kind of help. Therefore the overwhelming majority of
responses were based on self-completion and self-assessment.
Scores for each of the measures at baseline and one month and the change scores for the
cataract cohort are displayed in Table 2. Note that the mean change in the total score for the
NEI-VFQ-25 (VFQt) of 9.96 exceeds the guideline for a clinically important difference of
5.00. Similarly, the mean change in overall HUI3 scores exceeds the 0.03 clinically
important difference guideline. The mean change in HUI3 vision score and HUI2 sensation
scores exceed the 0.05 clinically important difference guideline. The mean changes in scores
for EQ-5D, QWB-SA, SF-6D, and SRH are less than the guidelines for a clinically
important difference. The distribution of change scores for the VFQt is displayed in Figure
1. Using the change of 5 or more in VFQt score as the criterion, 43% of patients improved,
52% were stable, and 4% got worse.
Scores for each of the measures at baseline and six months and the mean change scores for
the heart failure cohort are displayed in Table 3. Note the mean change of 8.72 in score for
the MLHF exceeds the 5.00 guideline for a clinically important difference. The mean change
in QWB-SA, SF-6D, and HUI3 scores exceed the guideline while the mean changes in
scores for the EQ-5D, HUI2, and SRH do not. The distribution of change scores for the
MLHF is displayed in Figure 2. Using the change of 5 or more in MLHF score as the
criterion, 47% of patients improved, 35% were stable, and 19% got worse.
Agreement among change scores
The ICC among the 10 measures of change in the cataract cohort was 0.16 (95% confidence
interval: 0.02 – 0.29). The ICC among the seven measures of change in the heart failure
cohort was 0.07 (95% confidence interval: −0.14 – 0.28).
Agreement Cataract cohort
The per cent agreement varies between 33% and 57% and is displayed in Table 4 along with
simple and weighted kappa statistics for agreement between pairs of measures in classifying
patients as improved, stable, or worse. The simple kappa statistics for six of the nine pairs
are poor and the kappa statistics for three of the pairs are fair. Fair agreement was obtained
between the NEI-VFQ-25 total scores and the vision-targeted measures: HUI2 sensation,
HUI3 vision, and the VFQ-UI. The results for weighted kappa are very similar to the results
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for the simple kappa. Results for the delta statistics are also very similar, ranging from −0.05
(VFQt and SRH) to 0.31 (VFQt and HUI3 vision) to 0.40 (VFQt and VFQ-UI). Area under
the curve results for the ROC analyses range from 0.44 (SRH) to 0.67 (HUI3 vision) to 0.72
(VFQ-UI). In many cases in the ROC analyses the area under the curve is less than 0.60,
indicating agreement little better than one would expect by chance. These results indicate
that the lack of agreement is not sensitive to the choice of cut points for clinically important
differences. Finally, results from secondary analyses for n = 315 (subjects for whom
observations on any measure was available at baseline and at the one-month follow-up) were
very similar to the results reported in Table 4 (data not shown).
Agreement heart failure cohort
The per cent agreement varies between 19% and 49% and is displayed along with simple
and weighted kappa statistics for agreement between pairs of measures in classifying
patients as improved, stable, or worse are for the heart failure cohort in Table 5. The simple
kappa statistics are negative for five pairs, indicating agreement less than that which would
occur by chance. Agreement between the MLFH and SRH is fair. Results for the weighted
kappa are very similar. The results for the delta statistics also indicate little agreement,
ranging from −0.33 (QWB-SA) to 0.26 (SRH). Area under the curve results from the ROC
analyses range from 0.31 (QWB-SA) to 0.73 (SRH) and indicate that the results are not
sensitive to the choice of cut points. Finally, results from secondary analyses for n = 110
(subjects for whom observations on any measure was available at baseline and at the six-
month follow-up) were very similar to the results reported in Table 5 (data now shown).
Agreement among measures on classification of patients as worse, stable, or improved
Results on the extent of agreement among measures in classifying patients as improved,
stable, or deteriorated for the cataract cohort are found in Table 6. Analogous results for the
heart failure cohort are found in Table 7. The lack of agreement among measures evident in
the ICC results reported above is evident in Tables 6 and 7. Nonetheless, many observations
are aligned “on the diagonal”, indicating that there is some agreement between the disease-
specific measures, VFQ and MLHF, and each of the five preference-based measures, on
which patients changed and which did not.
Discussion
There is very little pair-wise agreement between the disease-targeted measures and the five
preference-based measures about which patients improved, were stable, or deteriorated. In
general, agreement for the cataract cohort was poor and for the heart failure cohort
negligible. For the cataract cohort, the agreement between the relevant HUI single-attribute
(“disease-targeted”) scores and the NEI-VFQ-25, those for HUI2 sensation and HUI3 vision,
were the exceptions; agreement was fair. Agreement was also fair between the utility scored
and conventional versions of the NEI-VFQ-25. Given that both of these measures are based
on the same questionnaire, it is perhaps surprising that the agreement is only fair and is not
clearly higher than agreement between the NEI-VFQ-25 and HUI2 sensation and HUI3
vision. In the heart failure cohort, fair agreement was observed only for the SRH. On the
basis of the ROC analyses, the results reported here appear to be robust to the choice of cut
points for a clinically important change.
The agreement analyses treat the disease-targeted measure as the gold standard. Yet even
though there is evidence of cross-sectional and longitudinal construct validity for the two
disease-targeted measures, neither can be regarded as a true gold standard. Furthermore, that
vision-related or heart-related HRQL improved does not necessarily imply that overall
HRQL improved. It is possible that the side effects of interventions could more than offset
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the gains and therefore overall HRQL might not improve. It is also possible that even though
vision- or heart-related HRQL improved, overall HRQL did not due to the burdens
associated with comorbidities. The NEI-VFQ-25 asks subjects about a wide variety of
difficulties that they might experience due to limited vision, including reading, hobbies,
navigating, driving, going up and down stairs, interacting with others, dressing, and the
amount of assistance the subject needs from others. Similarly, the MLHF asks about
limitations in/problems with mobility, sexual activity, interacting with others, fatigue,
hobbies, worry, concentration, memory, and depression that the subject experiences due to
the subject’s heart condition. Although the breadth of coverage of these disease-targeted
measures probably reduces the scope for a discrepancy between trends in vision- or heart-
related HRQL and overall HRQL, it does not eliminate the possibility for such
discrepancies.
The results on overall change in measures underscore that scores from these five preference-
based measures are not interchangeable (Table 2). In the cataract cohort, using published
guidelines (2;57) on clinically important differences/changes, clearly clinically important
change was detected by the NEI-VFQ-25 and HUI3. Given that vision is included in HUI3
and that the NEI-VFQ-25 is a vision-targeted measure, this results is not surprising. But
vision is included in the QWB-SA and the overall score did not reflect the gain in HRQL
that was measured by the NEI-VFQ-25 and HUI3. Of course, it should be noted that only
the “worst” symptom for that subject in the QWB-SA is used to compute the overall score
and further that in a relatively elderly cohort, it is likely that many subjects were
experiencing symptoms that are more burdensome than impaired vision and thus the vision
item frequently did not affect the calculation of the QWB-SA score. Others have noted the
lack of responsiveness of the EQ-5D to the effects of cataract surgery(60).
For the heart failure cohort, using published guidelines (23–25;46;47;51) on clinically
important differences/changes, the MLHF, HUI3, QWB-SA, and SF-6D recorded clinically
important change. Fatigue and shortness of breath symptoms on the QWB-SA as well as the
mobility, physical, and social activity scales may have captured some of the effects of heart
failure on HRQL. Similarly, the physical functioning, vitality, and role attributes on SF-6D
may have registered some of the effects. HUI3 ambulation may have performed
similarly(61)
It should be noted that reliability is less than perfect for each of the measures used in the
study (62), so disagreement between change scores is also influenced by measurement error
and short-term fluctuations in health that are unrelated to the conditions of primary interest.
Change over time is measured with even less precision than absolute scores at a point in
time. Jones and Feeny (63) and Pickard et al. (64) found lower levels of agreement between
proxy and self-report for change scores than was evident for cross-sectional comparisons of
baseline and follow-up scores. Other investigators have pointed out that due to the size of
measurement error typically found in HRQL measures, change must be often be quite
substantial for measures to agree (62). Our results were not sensitive to the magnitude of
change that was considered clinically important, but the magnitude of true underlying
changes does influence the agreement that can be expected. Hence, some measures of
change may have better agreement than found in our studies, when reflecting interventions
with larger overall effects on HRQL.
Some limitations of the study should be noted. Because the analyses are based on subjects
for whom both baseline and the designated follow-up assessments were available, the results
are not necessarily representative of the experience of the entire inception cohorts. In the
cataract cohort those with and without complete data were similar. In the heart failure
cohort, those with missing data were older than those without missing data. If older patients
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experienced less improvement in HRQL than younger patients, it is possible that the
estimate of change based on subjects for whom we had complete data is biased upwards. As
noted in the Results, 7% of subjects had help in completing questionnaires so responses
could have been influenced by others. Another limitation is that while the scoring functions
for the QWB-SA and EQ-5D are based on preference scores from random samples of
community-dwelling adults in the US, the scoring functions for HUI2 and HUI3 are based
on preferences from random samples of the Canadian population and the function for the
SF-6D is based on UK preferences. There is evidence of the generalizability of the QWB
scoring function, (30;65;66) the HUI2 scoring function, (28;67) and the HUI3 scoring
function.(29;68–70) In contrast there is considerable variability across “national” EQ-5D
scoring functions. Nonetheless having not relied exclusively on US-based scoring functions
is unlikely to be an important factor influencing the results. Finally, we classified cataract
and heart failure patients as changed if the absolute value of their change score was ≥5.0
whether or not the difference was statistically significant. Hays et al. (71) note that changes
that are statistically significant at the level of an individual subject will typically exceed the
guideline for a clinically important difference(72).
Conclusions
The results underscore the lack of interchangeability of scores among these five widely used
preference-based measures. Not only are the absolute scores not necessarily interchangeable;
in these results the change scores were also not interchangeable (12). The results also point
to a lack of precision in estimating the magnitude of change in HRQL.
In making choices about which preference-based measure(s) to use in a study, investigators
need to consider carefully the coverage of the health-status classification systems and the
relevance of those systems to their clinical or population health application, evidence on the
cross-sectional construct validity of the measures in that application, and evidence of the
responsiveness (longitudinal construct validity) of the measures in that context. Further,
users of the results of studies that have employed preference-based measures to assess
HRQL need to interpret those results carefully.
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Table 6











− 4 13 21 38
0 7 39 73 119
+ 4 10 39 53
HUI2
− 8 16 22 46
0 2 20 39 61
+ 5 26 72 103
HUI3
− 8 20 30 58
0 3 14 32 49
+ 4 28 71 103
QWB-SA
− 11 27 34 72
0 2 12 39 53
+ 2 23 60 85
SF-6D
− 10 20 43 73
0 3 23 42 68
+ 2 19 48 69
SRH
− 1 7 27 35
0 7 46 84 137
+ 7 9 22 38
Note: - means Got Worse; 0 means Stayed Same; + means Showed Improvement.
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Table 7











− 11 6 16 33
0 16 2 8 26
+ 19 5 3 27
HUI2
− 11 6 13 30
0 8 5 5 18
+ 27 2 9 38
HUI3
− 10 8 14 32
0 10 3 4 17
+ 26 2 9 37
QWB-SA
− 9 6 15 30
0 7 3 5 15
+ 30 4 7 41
SF-6D
− 9 2 12 23
0 8 7 9 24
+ 29 4 6 39
SRH
− 24 3 4 31
0 20 8 13 41
+ 2 2 10 14
Note: - means Got Worse; 0 means Stayed Same; + means Showed Improvement.
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